To reduce payments to doctors by device manufacturers and pharma companies, the federal government instituted a regulatory policy, the Sunshine Act, in 2013. The goal was to allow the disinfecting nature of transparency to reduce the ethical problem of obligation when receiving "gifts." Two reports update how that battle seems to be going.
